Furthermore, SLC1A1 is involved in regulating the R-2-Hydroxyglutarate cancer metabolite (R-2-HG) and the hypoxia-inducible factor 1 alpha (HIF-1α)-SLC1A1 axis, further promoting tumor development (20–23). The gene discussed is SLC1A1; the disease is neoplasm.